SUZHOU, China – At the 3rd DIA China Drug Discovery Innovation, a director from the Ministry of Science and Technology (MOST) outlined the government's proposed plans to accelerate approvals for the collection of human genetic resources in keeping with the central government's overall strategy to support innovative drug development.